Privi Speciality Chemicals Limited · NSE:PRIVISCL
Privi Speciality Chemicals — Q4 FY25 Earnings Presentation
19 slides from Privi Speciality Chemicals's earnings presentation, May 5, 2025
Slide 1: Letter to BSE and NSE: Investor Presentation
+, May 05, 2025 The Manager (CRD) The Manager - Listing Department The BSE Limited National Stock Exchange of lndia Ltd Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot no, C/1, G Block, Dalal Street, Fort, Bandra-Kurla Complex, Bandra (East) Mumbai- 400001 Mumbai - 400 051 Scrip Code: 530tt7 Symbol:
Slide 2: Privi Speciality Chemicals Limited Investor Presentation – May 2025
Privi Speciality Chemicals Limited Investor Presentation – May 2025
Slide 3: Safe Harbor
Safe Harbor This presentation and the accompanying slides (the “Presentation”), which have been prepared by Privi Speciality Chemicals Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe fo
Slide 4: Q4 & FY25 Performance Highlights
Q4 & FY25 Performance Highlights 3
Slide 5: Highest Ever Quarterly & Annual Performance
Highest Ever Quarterly & Annual Performance Total Revenue EBITDA EBITDA Margin Profit After Tax Rs 628.37 Crores Rs 147.42 Crores 23.46% Rs 63.98 Crores Q4FY25 28% 50% 342 bps 101% Rs 2,121.84 Crores Rs 474.16 Crores 22.35% Rs 184.75 Crores FY25 19% 35% 260 bps 94% All growth are on Y-o-Y basis Key
Slide 6: From the CMD's Desk
From the CMD’s Desk We are delighted to report the highest-ever quarterly and annual financial performance in Privi’s history, marking a significant milestone in our journey of growth and excellence. This achievement reflects the passion, dedication and resilience of our entire team. Our core portfo
Slide 7: Steady Growth in Annual Performance
Steady Growth in Annual Performance Revenue (Rs. In Cr) EBITDA (Rs. In Cr) PAT (Rs. In Cr) 17.55% 15.75% 12.73% 19.95% 22.35% 9.02% 6.78% 1.31% 5.37% 8.71% Margin +13% 2,121.84 1,778.53 1,629.24 474.16 1,436.11 +20% +12.1% 184.75 1,296.52 354.82 116.90 227.54 226.24 97.38 95.43 207.34 21.28 FY21 FY2
Slide 8: Consolidated Profit & Loss Account
Consolidated Profit & Loss Account Particulars (Rs. Crores) Q4 FY25 Q4 FY24 YoY FY25 FY24 YoY Revenue from Operations 613.55 484.35 2,101.19 1,752.23 Other Income 14.82 7.58 20.65 26.30 Total Income 628.37 491.93 28% 2,121.84 1,778.53 19% Cost of materials consumed 340.49 275.45 1,131.49 1,009.38 Em
Slide 9: Consolidated Balance Sheet
Consolidated Balance Sheet Assets (Rs. Crores) Mar-25 Mar-24 Liabilities (Rs. Crores) Mar-25 Mar-24 Non Current assets Equity Property, Plant and Equipment 1,097.89 968.87 Equity Share capital 39.06 39.06 Capital work-in-progress 127.47 88.74 Other Equity 1,064.37 885.33 Intangible Assets 10.64 9.98
Slide 10: We Touch Your Lives Everyday
We Touch Your Lives Everyday
Slide 11: About Us
About Us Commenced 3+ decades of experience in Aroma Chemicals 1993 Manufacturing Operations 70+ Products Manufacturing Formidable Strength In Pine Chemistry 7 Facilities Presence across India's leading 30+ countries manufacturer, supplier & exporter of Aroma & Production 48,000+ Capacity (TPA) Frag
Slide 12: Our Journey
Our Journey • Turnover crossed Rs • Demerged ₹ 2,000 Cr from Fairchem • 3 New Products • Longer term Speciality • Launched contracts – • Indirectly Galaxmusk, Launched – Givaudan SA, P&G, listed as • Name change Camphor & Florovane, • Private Henkel to Privi Indomerane, Amber • Started • Turnover su
Slide 13: Core Values – 5S
Core Values – 5S Safety Key Recognitions • Safety Award (Sep 2023) – Recognized for the lowest accident frequency rate in the chemical industry. • National Safety Council (NSC) Certificate of Merit, Maharashtra Chapter’ Maharashtra Safety Award 2022, Maharashtra Chapter Certificate of Merit and NSC
Slide 14: Wide applications across F&F and FMCG with a diverse client base
Wide applications across F&F and FMCG with a diverse client base 70+ Product Offerings • Pinene • Citral • Musk & Speciality • Phenol • Value Added Fragrance • Fine Fragrance • Perfume • Candles • Air Fresheners • Incense Stick Home Care • Soaps • Floor Cleaner Serving the • • Detergent Handwash evo
Slide 15: State of the Art Manufacturing Facilities Backed by In-House R&D
State of the Art Manufacturing Facilities Backed by In-House R&D Location Mahad, Maharashtra Jhagadia, Gujarat Production Capacity 2 R&D Mahad & Nerul, No. of Units 6 1 48,000+ MTPA centers Maharashtra • Amber Fleur • OTBCHA • Dihydromyrcenol • PTBCHA R&D team strength including Employee strength Ma
Slide 16: Evolving Lifestyles Leads to Perpetual Rising Demand
Evolving Lifestyles Leads to Perpetual Rising Demand World Population (In Bn) 8.2 7.5 6.6 5.7 Population growth is 4.9 4.1 fueling a surge in 3.3 personal care 2.7 consumption. 1955 1965 1975 1985 1995 2005 2015 2025 Earlier Now Rising Demand for Aroma Chemicals • Surge in Niche fragrance requiremen
Slide 17: Expanding Core Capacities while launching New Products
Expanding Core Capacities while launching New Products Expanding Capacity for Existing Products In MTPA Driving innovation with new launches like Indomerane, Florovane and Amber Woody Xtreme 54,000 48,000 6,000 From the intermediates of the Galaxmusk, the Company has launched the value-added product
Slide 18: Way Forward
Way Forward • Safety • Sustainability Growth Propelled by 5S • Sence of Urgency • Super Transparency • Sincere Respect & Care Ongoing efforts to discover new avenues to create value in an Premiumisation ever-evolving digital landscape allow us to adapt to the dynamic needs of customers, unlocking po
Slide 19: Thank You
Thank You Company: Privi Speciality Chemicals Ltd. CIN – L15140MH1985PLC286828 Mr. Narayan S. Iyer – Chief Financial Officer Email – investors@privi.co.in www.privi.com Investor Relations Advisor : http://www.sgapl.net/images/sgapl_logo.jpg Strategic Growth Advisors Pvt. Ltd. CIN - U74140MH2010PTC20
Privi Speciality Chemicals — Q4 FY25 Earnings Presentation on 6ix